Search - tctmd.com

Displaying 61 - 80 of 238

Sort: Relevancy | Date

Presentation TCT 2018

Revascularization in Cardiogenic Shock: New Insights

Presenter: Jeroen J. Bax, Stephan Windecker, Holger Thiele

September 21, 2018

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

Presentation TCT 2018

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Presenter: Jeroen J. Bax, Stephan Windecker, Javier Escaned

September 21, 2018

Presentation TCT 2018

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

Presenter: Jeroen J. Bax, Stephan Windecker, Adrian P. Banning

September 21, 2018

Presentation TCT 2018

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

Presentation The Structural Heart Disease Summit 2018

TR Repair vs Replacement Strategies: Lessons From Surgery

Presenter: Georg Nickenig, Stephan Windecker, Gilbert H.L. Tang

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

Presenter: Georg Nickenig, Stephan Windecker, Steven F. Bolling

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Presenter: Georg Nickenig, Stephan Windecker, Neil P. Fam

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

Presenter: Georg Nickenig, Stephan Windecker, Ori Ben-Yehuda

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat

June 21, 2018

Presentation TCT 2017

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

Presenter: Antonio Colombo, David E. Kandzari, Stephan Windecker

October 31, 2017

Presentation TCT 2017

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Presenter: Giulio G. Stefanini, Stephan Windecker, Philip M. Urban

October 30, 2017

Presentation TCT 2017

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Presenter: Giulio G. Stefanini, Stephan Windecker, Antonio Colombo

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Presenter: Giulio G. Stefanini, Stephan Windecker, Stefan K. James

October 30, 2017

Presentation TCT 2017

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Presenter: Giulio G. Stefanini, Stephan Windecker, Elvin Kedhi

October 30, 2017

Advertisement

Revascularization in Cardiogenic Shock: New Insights

What is the Future of Bioresorbable Scaffolds?

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

MITRA-FR: No Benefit of MitraClip in Functional MR

TR Repair vs Replacement Strategies: Lessons From Surgery

When Should the Tricuspid Valve Be Repaired During Mitral Valve Surgery?

TR Due to Pacemaker Lead Entrapment: Frequency, Diagnosis, Clinical Consequencs, and Treatment Alternatives

Medical Therapy for TR and Indications (Thresholds) for Surgical/Transcatheter Therapies

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Should Recommendations for Left Main PCI Be Revised? Personal Perspectives and the Guidelines Process

Controversial Position Statement: Polymer-Free DES Provide the Optimal Balance of Safety and Efficacy (and Will Improve Most in the Future)!

Metallic DES Are Different! How I Choose Stent Type to Match the Lesion and Patient (From 30 Years of Experience)

Are All Contemporary DES Comparable? Lessons From the SCAAR Registry

Are All Contemporary DES Comparable? Lessons From the COMPARE Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content